Your browser doesn't support javascript.
loading
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade, Raúl J; Aithal, Guruprasad P; de Boer, Ynto S; Liberal, Rodrigo; Gerbes, Alexander; Regev, Arie; Terziroli Beretta-Piccoli, Benedetta; Schramm, Christoph; Kleiner, David E; De Martin, Eleonora; Kullak-Ublick, Gerd A; Stirnimann, Guido; Devarbhavi, Harshad; Vierling, John M; Manns, Michael P; Sebode, Marcial; Londoño, Maria Carlota; Avigan, Mark; Robles-Diaz, Mercedes; García-Cortes, Miren; Atallah, Edmond; Heneghan, Michael; Chalasani, Naga; Trivedi, Palak J; Hayashi, Paul H; Taubert, Richard; Fontana, Robert J; Weber, Sabine; Oo, Ye Htun; Zen, Yoh; Licata, Anna; Lucena, M Isabel; Mieli-Vergani, Giorgina; Vergani, Diego; Björnsson, Einar S.
Afiliação
  • Andrade RJ; Servicio Aparato Digestivo and Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA_Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestiva
  • Aithal GP; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
  • de Boer YS; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, Netherlands.
  • Liberal R; Gastroenterology Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Gerbes A; Department of Medicine II, LMU Klinikum Munich, Munich, Germany.
  • Regev A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Terziroli Beretta-Piccoli B; Università della Svizzera Italiana, Facoltà di Scienze Biomediche. Epatocentro, Lugano, Switzerland.
  • Schramm C; Department of Medicine, University Medical Center Hamburg-Eppendorf. Hamburg Center for Translational Immunology. Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kleiner DE; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • De Martin E; APHP, Hôpital Paul Brousse, Centre Hépato-Biliaire, INSERM Unit 1193, FHU Hepatinov, Villejuif, France.
  • Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Mechanistic Safety, Global Drug Development, Novartis, Basel, Switzerland.
  • Stirnimann G; Department of Visceral Surgery and Medicine, Inselspital University Hospital and University of Bern, Bern, Switzerland.
  • Devarbhavi H; Department of Gastroenterology and Hepatology, St. John's Medical College Hospital, Bangalore, India.
  • Vierling JM; Departments of Medicine and Surgery, Section of Gastroenterology and Hepatology and Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, United States.
  • Manns MP; Hannover Medical School, Centre of ERN RARE-LIVER, Hannover, Germany.
  • Sebode M; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.
  • Londoño MC; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain; Liver Unit, Hospital Clínic de Barcelona, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver), Institut d' Investigacions Biomédiques August Pi i Sunyer (
  • Avigan M; Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Robles-Diaz M; Servicio Aparato Digestivo and Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA_Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestiva
  • García-Cortes M; Servicio Aparato Digestivo and Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA_Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestiva
  • Atallah E; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
  • Heneghan M; Institute of Liver Studies, King's College Hospital, London, UK.
  • Chalasani N; University School of Medicine & Indiana University Health, Indianapolis, Indiana, USA.
  • Trivedi PJ; NIHR Birmingham BRC, Institute of Immunology and Immunotherapy, Centre for Liver and Gastrointestinal Research, Liver Unit, University Hospitals Birmingham National Health Service Foundation Trust Queen Elizabeth, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Hayashi PH; Division of Hepatology and Nutrition, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Taubert R; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hannover, Germany.
  • Fontana RJ; Division of Gastroenterology and Hepatology, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Weber S; Department of Medicine II, LMU Klinikum Munich, Munich, Germany.
  • Oo YH; Center for Liver and Gastro Research & National Institute of Health Research Birmingham Biomedical Research Centre, University of Birmingham, Centre for Rare Disease and ERN Rare Liver Centre, Liver Transplant and Hepatobiliary Unit, University Hospital Birmingham NHS Foundation Trust, UK.
  • Zen Y; Institute of Liver Studies, King's College Hospital, London SE5 9RS, UK.
  • Licata A; Medicina Interna ed Epatologia, Università degli Studi di Palermo, Palermo, Italy.
  • Lucena MI; Servicio Aparato Digestivo and Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA_Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestiva
  • Mieli-Vergani G; MowatLabs, Faculty of Life Sciences and Medicine, King's College London, King's College Hospital, London, United Kingdom.
  • Vergani D; MowatLabs, Faculty of Life Sciences and Medicine, King's College London, King's College Hospital, London, United Kingdom.
  • Björnsson ES; Faculty of Medicine, University of Iceland, Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland.
J Hepatol ; 79(3): 853-866, 2023 09.
Article em En | MEDLINE | ID: mdl-37164270
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite Autoimune / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite Autoimune / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article